InsidersTradesSigma
Follow the 드림씨아이에스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 드림씨아이에스 has published 1 insider filings. Market capitalisation: €70.4bn. The latest transaction was filed on 6 April 2026 (Purchase). Among the most active insiders: 유정희. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
드림씨아이에스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for the medical sector.